𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Continuous intravenous infusions of 5-fluoro-2′-deoxyuridine in the treatment of solid tumors

✍ Scribed by Ronald C. Deconti; Stephen R. Kaplan; Rose J. Papac; Paul Calabresi

Publisher
John Wiley and Sons
Year
1973
Tongue
English
Weight
328 KB
Volume
31
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

9-aminocamptothecin by 72-hour continuou
9-aminocamptothecin by 72-hour continuous intravenous infusion is Inactive in the treatment of patients with 5-fluorouracil-refractory colorectal carcinoma
✍ Leonard B. Saltz; Nancy E. Kemeny; William Tong; John Harrison; Regina Berkery; 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB 👁 2 views

thecin, have shown outstanding preclinical activity against colorectal carcinoma. Irinotecan (CPT-11), another camptothecin derivative, has demonstrated clinical

Cisplatin, continuous-infusion 5-fluorou
Cisplatin, continuous-infusion 5-fluorouracil, and intermediate-dose methotrexate in the treatment of unresectable non-small cell carcinoma of the lung
✍ Catherine A. Wheeler; Lawrence N. Shulman; Steven E. Come; Lowell E. Schnipper; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 2 views

Forty-one patients with unresectable non-small cell carcinoma of the lung (NSCCL) were treated with cisplatin 20 mg/m2/d for 5 days as a daily bolus injection, 5-fluorouracil 800 mg/m2/d by continuous infusion for 5 days, and intermediate-dose methotrexate 200 mg/m2 on days 15 and 22 of a 28-day cyc